Banner

This study highlights the ability of the SureSeq™ Myeloid Fusion Panel to detect multiple fusions, identify breakpoints, and capture MECOM overexpression, so your lab can achieve higher efficiency sample classification with a single assay.

This application note will evidence:

  • The concordance of the SureSeq Myeloid Fusion Panel with orthogonal methods
  • The panel's confident detection of MECOM expression
  • The partner-agnostic fusion detection capability of the panel, including breakpoints identified in 3 KMT2A rearrangements

Share your details to gain access

  • Share